Tokyo, Aug. 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062410) titled 'Testing the impact of Psychological intervention on work stress among Agric... Read More
Tokyo, Aug. 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062033) titled 'Meteorological and Environmental Factors Associated with the Onset of Subar... Read More
Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (ACTRN12626001040358) titled 'FIDAA - Understanding the Experience of People Receiving Escalating Fi... Read More
Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (ACTRN12626001038381) titled 'Effect of intensive telemonitoring on Continuous Positive Airways Pres... Read More
Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (ACTRN12626001035314) titled 'Development of a markerless approach to abdominal motion tracking duri... Read More
Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (ACTRN12626001039370) titled 'A randomised controlled trial evaluating the efficacy of multi-wavelen... Read More
Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More
Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More
Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More
Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More